Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
DW91170
i
Other names:
DW91170
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
Dong Wha
Drug class:
EZH2 inhibitor, EZH1 inhibitor
Related drugs:
‹
tazemetostat (15)
GSK2816126 (5)
CPI-169 (3)
JQEZ5 (2)
SHR2554 (2)
EZH2 inhibitor (1)
valemetostat (1)
HM97594 (1)
UNC1999 (1)
CPI-0209 (1)
tazemetostat (15)
GSK2816126 (5)
CPI-169 (3)
JQEZ5 (2)
SHR2554 (2)
EZH2 inhibitor (1)
valemetostat (1)
HM97594 (1)
UNC1999 (1)
CPI-0209 (1)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
EZH2 Y641
Diffuse Large B Cell Lymphoma
EZH2 Y641
Diffuse Large B Cell Lymphoma
DW91170
Sensitive: D – Preclinical
AACR 2023 - 1 week (New D)
DW91170
Sensitive
:
D
AACR 2023 - 1wk
DW91170
Sensitive: D – Preclinical
AACR 2023 - 1 week
DW91170
Sensitive
:
D
AACR 2023 - 1 week - (New D)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login